share_log

Morgan Stanley Downgrades Vaccitech to Equal-Weight, Lowers Price Target to $3.25

Morgan Stanley Downgrades Vaccitech to Equal-Weight, Lowers Price Target to $3.25

摩根士丹利将Vaccitech的评级下调至同等权重,将目标股价下调至3.25美元
Benzinga ·  2023/09/25 05:41

Morgan Stanley analyst Matthew Harrison downgrades Vaccitech (NASDAQ:VACC) from Overweight to Equal-Weight and lowers the price target from $14 to $3.25.

摩根士丹利分析师马修·哈里森将Vaccitech(纳斯达克股票代码:VACC)的评级从增持下调至同等权重,并将目标股价从14美元下调至3.25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发